Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
161,353
archived clinical trials in
Cancer

Nivolumab (BMS-936558; MDX-1106) in Combination With Sunitinib, Pazopanib, or Ipilimumab in Subjects With Metastatic Renal Cell Carcinoma (RCC) (CheckMate 016)
A Phase 1 Study of Nivolumab (BMS-936558) Plus Sunitinib, Pazopanib or Ipilimumab in Subjects With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  1/31/2017
Fox Chase Cancer Center
mi
from
Philadelphia, PA
Nivolumab (BMS-936558; MDX-1106) in Combination With Sunitinib, Pazopanib, or Ipilimumab in Subjects With Metastatic Renal Cell Carcinoma (RCC) (CheckMate 016)
A Phase 1 Study of Nivolumab (BMS-936558) Plus Sunitinib, Pazopanib or Ipilimumab in Subjects With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 1/31/2017
Fox Chase Cancer Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Nivolumab (BMS-936558; MDX-1106) in Combination With Sunitinib, Pazopanib, or Ipilimumab in Subjects With Metastatic Renal Cell Carcinoma (RCC) (CheckMate 016)
A Phase 1 Study of Nivolumab (BMS-936558) Plus Sunitinib, Pazopanib or Ipilimumab in Subjects With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  1/31/2017
Tom Baker Cancer Centre
mi
from
Calgary,
Nivolumab (BMS-936558; MDX-1106) in Combination With Sunitinib, Pazopanib, or Ipilimumab in Subjects With Metastatic Renal Cell Carcinoma (RCC) (CheckMate 016)
A Phase 1 Study of Nivolumab (BMS-936558) Plus Sunitinib, Pazopanib or Ipilimumab in Subjects With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 1/31/2017
Tom Baker Cancer Centre
mi
from
Calgary,
Click here to add this to my saved trials
The Safety and Efficacy of Methylene Blue MMX® Modified Release Tablets Administered to Subjects Undergoing Screening or Surveillance Colonoscopy
The Safety and Efficacy of Methylene Blue MMX® Modified Release Tablets Administered to Subjects Undergoing Screening or Surveillance Colonoscopy
Status: Enrolling
Updated:  1/31/2017
Dr Michelle Young
mi
from
Phoenix, AZ
The Safety and Efficacy of Methylene Blue MMX® Modified Release Tablets Administered to Subjects Undergoing Screening or Surveillance Colonoscopy
The Safety and Efficacy of Methylene Blue MMX® Modified Release Tablets Administered to Subjects Undergoing Screening or Surveillance Colonoscopy
Status: Enrolling
Updated: 1/31/2017
Dr Michelle Young
mi
from
Phoenix, AZ
Click here to add this to my saved trials
The Safety and Efficacy of Methylene Blue MMX® Modified Release Tablets Administered to Subjects Undergoing Screening or Surveillance Colonoscopy
The Safety and Efficacy of Methylene Blue MMX® Modified Release Tablets Administered to Subjects Undergoing Screening or Surveillance Colonoscopy
Status: Enrolling
Updated:  1/31/2017
Dr Francesco Ramirez
mi
from
Scottsdale, AZ
The Safety and Efficacy of Methylene Blue MMX® Modified Release Tablets Administered to Subjects Undergoing Screening or Surveillance Colonoscopy
The Safety and Efficacy of Methylene Blue MMX® Modified Release Tablets Administered to Subjects Undergoing Screening or Surveillance Colonoscopy
Status: Enrolling
Updated: 1/31/2017
Dr Francesco Ramirez
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
The Safety and Efficacy of Methylene Blue MMX® Modified Release Tablets Administered to Subjects Undergoing Screening or Surveillance Colonoscopy
The Safety and Efficacy of Methylene Blue MMX® Modified Release Tablets Administered to Subjects Undergoing Screening or Surveillance Colonoscopy
Status: Enrolling
Updated:  1/31/2017
Dr David Gatof
mi
from
Lafayette, CO
The Safety and Efficacy of Methylene Blue MMX® Modified Release Tablets Administered to Subjects Undergoing Screening or Surveillance Colonoscopy
The Safety and Efficacy of Methylene Blue MMX® Modified Release Tablets Administered to Subjects Undergoing Screening or Surveillance Colonoscopy
Status: Enrolling
Updated: 1/31/2017
Dr David Gatof
mi
from
Lafayette, CO
Click here to add this to my saved trials
The Safety and Efficacy of Methylene Blue MMX® Modified Release Tablets Administered to Subjects Undergoing Screening or Surveillance Colonoscopy
The Safety and Efficacy of Methylene Blue MMX® Modified Release Tablets Administered to Subjects Undergoing Screening or Surveillance Colonoscopy
Status: Enrolling
Updated:  1/31/2017
Dr Michael Wallace
mi
from
Jacksonville, FL
The Safety and Efficacy of Methylene Blue MMX® Modified Release Tablets Administered to Subjects Undergoing Screening or Surveillance Colonoscopy
The Safety and Efficacy of Methylene Blue MMX® Modified Release Tablets Administered to Subjects Undergoing Screening or Surveillance Colonoscopy
Status: Enrolling
Updated: 1/31/2017
Dr Michael Wallace
mi
from
Jacksonville, FL
Click here to add this to my saved trials
The Safety and Efficacy of Methylene Blue MMX® Modified Release Tablets Administered to Subjects Undergoing Screening or Surveillance Colonoscopy
The Safety and Efficacy of Methylene Blue MMX® Modified Release Tablets Administered to Subjects Undergoing Screening or Surveillance Colonoscopy
Status: Enrolling
Updated:  1/31/2017
Dr Prateek Sharma
mi
from
Kansas City, KA
The Safety and Efficacy of Methylene Blue MMX® Modified Release Tablets Administered to Subjects Undergoing Screening or Surveillance Colonoscopy
The Safety and Efficacy of Methylene Blue MMX® Modified Release Tablets Administered to Subjects Undergoing Screening or Surveillance Colonoscopy
Status: Enrolling
Updated: 1/31/2017
Dr Prateek Sharma
mi
from
Kansas City, KA
Click here to add this to my saved trials
The Safety and Efficacy of Methylene Blue MMX® Modified Release Tablets Administered to Subjects Undergoing Screening or Surveillance Colonoscopy
The Safety and Efficacy of Methylene Blue MMX® Modified Release Tablets Administered to Subjects Undergoing Screening or Surveillance Colonoscopy
Status: Enrolling
Updated:  1/31/2017
Dr Marcia Canto
mi
from
Baltimore, MD
The Safety and Efficacy of Methylene Blue MMX® Modified Release Tablets Administered to Subjects Undergoing Screening or Surveillance Colonoscopy
The Safety and Efficacy of Methylene Blue MMX® Modified Release Tablets Administered to Subjects Undergoing Screening or Surveillance Colonoscopy
Status: Enrolling
Updated: 1/31/2017
Dr Marcia Canto
mi
from
Baltimore, MD
Click here to add this to my saved trials
The Safety and Efficacy of Methylene Blue MMX® Modified Release Tablets Administered to Subjects Undergoing Screening or Surveillance Colonoscopy
The Safety and Efficacy of Methylene Blue MMX® Modified Release Tablets Administered to Subjects Undergoing Screening or Surveillance Colonoscopy
Status: Enrolling
Updated:  1/31/2017
Dr David Bruining
mi
from
Rochester, MN
The Safety and Efficacy of Methylene Blue MMX® Modified Release Tablets Administered to Subjects Undergoing Screening or Surveillance Colonoscopy
The Safety and Efficacy of Methylene Blue MMX® Modified Release Tablets Administered to Subjects Undergoing Screening or Surveillance Colonoscopy
Status: Enrolling
Updated: 1/31/2017
Dr David Bruining
mi
from
Rochester, MN
Click here to add this to my saved trials
The Safety and Efficacy of Methylene Blue MMX® Modified Release Tablets Administered to Subjects Undergoing Screening or Surveillance Colonoscopy
The Safety and Efficacy of Methylene Blue MMX® Modified Release Tablets Administered to Subjects Undergoing Screening or Surveillance Colonoscopy
Status: Enrolling
Updated:  1/31/2017
Dr Raf Bisschop
mi
from
Leuven,
The Safety and Efficacy of Methylene Blue MMX® Modified Release Tablets Administered to Subjects Undergoing Screening or Surveillance Colonoscopy
The Safety and Efficacy of Methylene Blue MMX® Modified Release Tablets Administered to Subjects Undergoing Screening or Surveillance Colonoscopy
Status: Enrolling
Updated: 1/31/2017
Dr Raf Bisschop
mi
from
Leuven,
Click here to add this to my saved trials
Food Effect Study of Abiraterone Acetate for Treatment of Patients With Castration-Resistant Prostate Cancer
A Prospective Randomized Pilot Study Evaluating the Food Effect on the Pharmacokinetics and Pharmacodynamics of Abiraterone Acetate in Men With Castrate Resistant Prostate Cancer
Status: Enrolling
Updated:  2/1/2017
Emory University/Winship Cancer Institute
mi
from
Atlanta, GA
Food Effect Study of Abiraterone Acetate for Treatment of Patients With Castration-Resistant Prostate Cancer
A Prospective Randomized Pilot Study Evaluating the Food Effect on the Pharmacokinetics and Pharmacodynamics of Abiraterone Acetate in Men With Castrate Resistant Prostate Cancer
Status: Enrolling
Updated: 2/1/2017
Emory University/Winship Cancer Institute
mi
from
Atlanta, GA
Click here to add this to my saved trials
Food Effect Study of Abiraterone Acetate for Treatment of Patients With Castration-Resistant Prostate Cancer
A Prospective Randomized Pilot Study Evaluating the Food Effect on the Pharmacokinetics and Pharmacodynamics of Abiraterone Acetate in Men With Castrate Resistant Prostate Cancer
Status: Enrolling
Updated:  2/1/2017
University of Chicago
mi
from
Chicago, IL
Food Effect Study of Abiraterone Acetate for Treatment of Patients With Castration-Resistant Prostate Cancer
A Prospective Randomized Pilot Study Evaluating the Food Effect on the Pharmacokinetics and Pharmacodynamics of Abiraterone Acetate in Men With Castrate Resistant Prostate Cancer
Status: Enrolling
Updated: 2/1/2017
University of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Food Effect Study of Abiraterone Acetate for Treatment of Patients With Castration-Resistant Prostate Cancer
A Prospective Randomized Pilot Study Evaluating the Food Effect on the Pharmacokinetics and Pharmacodynamics of Abiraterone Acetate in Men With Castrate Resistant Prostate Cancer
Status: Enrolling
Updated:  2/1/2017
North Shore University Health System
mi
from
Evanston, IL
Food Effect Study of Abiraterone Acetate for Treatment of Patients With Castration-Resistant Prostate Cancer
A Prospective Randomized Pilot Study Evaluating the Food Effect on the Pharmacokinetics and Pharmacodynamics of Abiraterone Acetate in Men With Castrate Resistant Prostate Cancer
Status: Enrolling
Updated: 2/1/2017
North Shore University Health System
mi
from
Evanston, IL
Click here to add this to my saved trials
Food Effect Study of Abiraterone Acetate for Treatment of Patients With Castration-Resistant Prostate Cancer
A Prospective Randomized Pilot Study Evaluating the Food Effect on the Pharmacokinetics and Pharmacodynamics of Abiraterone Acetate in Men With Castrate Resistant Prostate Cancer
Status: Enrolling
Updated:  2/1/2017
Ingalls Memorial Hospital
mi
from
Harvey, IL
Food Effect Study of Abiraterone Acetate for Treatment of Patients With Castration-Resistant Prostate Cancer
A Prospective Randomized Pilot Study Evaluating the Food Effect on the Pharmacokinetics and Pharmacodynamics of Abiraterone Acetate in Men With Castrate Resistant Prostate Cancer
Status: Enrolling
Updated: 2/1/2017
Ingalls Memorial Hospital
mi
from
Harvey, IL
Click here to add this to my saved trials
Food Effect Study of Abiraterone Acetate for Treatment of Patients With Castration-Resistant Prostate Cancer
A Prospective Randomized Pilot Study Evaluating the Food Effect on the Pharmacokinetics and Pharmacodynamics of Abiraterone Acetate in Men With Castrate Resistant Prostate Cancer
Status: Enrolling
Updated:  2/1/2017
Illinois Cancer Care
mi
from
Peoria, IL
Food Effect Study of Abiraterone Acetate for Treatment of Patients With Castration-Resistant Prostate Cancer
A Prospective Randomized Pilot Study Evaluating the Food Effect on the Pharmacokinetics and Pharmacodynamics of Abiraterone Acetate in Men With Castrate Resistant Prostate Cancer
Status: Enrolling
Updated: 2/1/2017
Illinois Cancer Care
mi
from
Peoria, IL
Click here to add this to my saved trials
Food Effect Study of Abiraterone Acetate for Treatment of Patients With Castration-Resistant Prostate Cancer
A Prospective Randomized Pilot Study Evaluating the Food Effect on the Pharmacokinetics and Pharmacodynamics of Abiraterone Acetate in Men With Castrate Resistant Prostate Cancer
Status: Enrolling
Updated:  2/1/2017
National University Hospital
mi
from
Singapore,
Food Effect Study of Abiraterone Acetate for Treatment of Patients With Castration-Resistant Prostate Cancer
A Prospective Randomized Pilot Study Evaluating the Food Effect on the Pharmacokinetics and Pharmacodynamics of Abiraterone Acetate in Men With Castrate Resistant Prostate Cancer
Status: Enrolling
Updated: 2/1/2017
National University Hospital
mi
from
Singapore,
Click here to add this to my saved trials
DAMES: Daughters And MothErS Against Breast Cancer
DAMES: Daughters And MothErS Against Breast Cancer
Status: Enrolling
Updated:  2/1/2017
Duke Univ Med Ctr
mi
from
Durham, NC
DAMES: Daughters And MothErS Against Breast Cancer
DAMES: Daughters And MothErS Against Breast Cancer
Status: Enrolling
Updated: 2/1/2017
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
DAMES: Daughters And MothErS Against Breast Cancer
DAMES: Daughters And MothErS Against Breast Cancer
Status: Enrolling
Updated:  2/1/2017
UT MD Anderson Cancer Center
mi
from
Houston, TX
DAMES: Daughters And MothErS Against Breast Cancer
DAMES: Daughters And MothErS Against Breast Cancer
Status: Enrolling
Updated: 2/1/2017
UT MD Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Hypoxia-positron Emission Tomography (PET) and Intensity Modulated Proton Therapy (IMPT) Dose Painting in Patients With Chordomas
Hypoxia-PET and IMPT Dose Painting in Patients With Chordomas: A Pilot Study
Status: Enrolling
Updated:  2/2/2017
Massachusetts General Hospital
mi
from
Boston, MA
Hypoxia-positron Emission Tomography (PET) and Intensity Modulated Proton Therapy (IMPT) Dose Painting in Patients With Chordomas
Hypoxia-PET and IMPT Dose Painting in Patients With Chordomas: A Pilot Study
Status: Enrolling
Updated: 2/2/2017
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Optimal Tube Feeding Method in Head and Neck Cancer Patients
The Optimal Tube Feeding Method in Head and Neck Cancer Patients: A Comparison Between Bolus, Gravity, and Tube Feeding Pump.
Status: Enrolling
Updated:  2/2/2017
Charles A. Sammons Cancer Center at Baylor University Medical Center
mi
from
Dallas, TX
Optimal Tube Feeding Method in Head and Neck Cancer Patients
The Optimal Tube Feeding Method in Head and Neck Cancer Patients: A Comparison Between Bolus, Gravity, and Tube Feeding Pump.
Status: Enrolling
Updated: 2/2/2017
Charles A. Sammons Cancer Center at Baylor University Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Optimal Tube Feeding Method in Head and Neck Cancer Patients
The Optimal Tube Feeding Method in Head and Neck Cancer Patients: A Comparison Between Bolus, Gravity, and Tube Feeding Pump.
Status: Enrolling
Updated:  2/2/2017
Charles A. Sammons Cancer Center at Baylor University Medical Center
mi
from
Dallas, TX
Optimal Tube Feeding Method in Head and Neck Cancer Patients
The Optimal Tube Feeding Method in Head and Neck Cancer Patients: A Comparison Between Bolus, Gravity, and Tube Feeding Pump.
Status: Enrolling
Updated: 2/2/2017
Charles A. Sammons Cancer Center at Baylor University Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
A Brief Patient-Controlled Intervention for a Symptom Cluster in Advanced Cancer
A Brief Patient-Controlled Intervention for a Symptom Cluster in Advanced Cancer
Status: Enrolling
Updated:  2/2/2017
SwedishAmerican Regional Cancer Center
mi
from
Rockford, IL
A Brief Patient-Controlled Intervention for a Symptom Cluster in Advanced Cancer
A Brief Patient-Controlled Intervention for a Symptom Cluster in Advanced Cancer
Status: Enrolling
Updated: 2/2/2017
SwedishAmerican Regional Cancer Center
mi
from
Rockford, IL
Click here to add this to my saved trials
A Brief Patient-Controlled Intervention for a Symptom Cluster in Advanced Cancer
A Brief Patient-Controlled Intervention for a Symptom Cluster in Advanced Cancer
Status: Enrolling
Updated:  2/2/2017
Mercy Health System
mi
from
Janesville, WI
A Brief Patient-Controlled Intervention for a Symptom Cluster in Advanced Cancer
A Brief Patient-Controlled Intervention for a Symptom Cluster in Advanced Cancer
Status: Enrolling
Updated: 2/2/2017
Mercy Health System
mi
from
Janesville, WI
Click here to add this to my saved trials
A Brief Patient-Controlled Intervention for a Symptom Cluster in Advanced Cancer
A Brief Patient-Controlled Intervention for a Symptom Cluster in Advanced Cancer
Status: Enrolling
Updated:  2/2/2017
University of Wisconsin
mi
from
Madison, WI
A Brief Patient-Controlled Intervention for a Symptom Cluster in Advanced Cancer
A Brief Patient-Controlled Intervention for a Symptom Cluster in Advanced Cancer
Status: Enrolling
Updated: 2/2/2017
University of Wisconsin
mi
from
Madison, WI
Click here to add this to my saved trials
A Brief Patient-Controlled Intervention for a Symptom Cluster in Advanced Cancer
A Brief Patient-Controlled Intervention for a Symptom Cluster in Advanced Cancer
Status: Enrolling
Updated:  2/2/2017
ProHealth Care, Inc
mi
from
Waukesha, WI
A Brief Patient-Controlled Intervention for a Symptom Cluster in Advanced Cancer
A Brief Patient-Controlled Intervention for a Symptom Cluster in Advanced Cancer
Status: Enrolling
Updated: 2/2/2017
ProHealth Care, Inc
mi
from
Waukesha, WI
Click here to add this to my saved trials
Evolution® Biliary Stent System-Fully Covered
Evaluation for the Effectiveness of Evolution® Biliary Stent System-Fully Covered
Status: Enrolling
Updated:  2/2/2017
University of Colorado Hospital
mi
from
Aurora, CO
Evolution® Biliary Stent System-Fully Covered
Evaluation for the Effectiveness of Evolution® Biliary Stent System-Fully Covered
Status: Enrolling
Updated: 2/2/2017
University of Colorado Hospital
mi
from
Aurora, CO
Click here to add this to my saved trials
Evolution® Biliary Stent System-Fully Covered
Evaluation for the Effectiveness of Evolution® Biliary Stent System-Fully Covered
Status: Enrolling
Updated:  2/2/2017
Borland-Groover Clinic
mi
from
Jacksonville, FL
Evolution® Biliary Stent System-Fully Covered
Evaluation for the Effectiveness of Evolution® Biliary Stent System-Fully Covered
Status: Enrolling
Updated: 2/2/2017
Borland-Groover Clinic
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Evolution® Biliary Stent System-Fully Covered
Evaluation for the Effectiveness of Evolution® Biliary Stent System-Fully Covered
Status: Enrolling
Updated:  2/2/2017
Moffitt Cancer Center
mi
from
Tampa, FL
Evolution® Biliary Stent System-Fully Covered
Evaluation for the Effectiveness of Evolution® Biliary Stent System-Fully Covered
Status: Enrolling
Updated: 2/2/2017
Moffitt Cancer Center
mi
from
Tampa, FL
Click here to add this to my saved trials
Evolution® Biliary Stent System-Fully Covered
Evaluation for the Effectiveness of Evolution® Biliary Stent System-Fully Covered
Status: Enrolling
Updated:  2/2/2017
Indiana University Hospital
mi
from
Indianapolis, IN
Evolution® Biliary Stent System-Fully Covered
Evaluation for the Effectiveness of Evolution® Biliary Stent System-Fully Covered
Status: Enrolling
Updated: 2/2/2017
Indiana University Hospital
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Evolution® Biliary Stent System-Fully Covered
Evaluation for the Effectiveness of Evolution® Biliary Stent System-Fully Covered
Status: Enrolling
Updated:  2/2/2017
Wake Forest Baptist Medical Center
mi
from
Winston-Salem, NC
Evolution® Biliary Stent System-Fully Covered
Evaluation for the Effectiveness of Evolution® Biliary Stent System-Fully Covered
Status: Enrolling
Updated: 2/2/2017
Wake Forest Baptist Medical Center
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Evolution® Biliary Stent System-Fully Covered
Evaluation for the Effectiveness of Evolution® Biliary Stent System-Fully Covered
Status: Enrolling
Updated:  2/2/2017
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Evolution® Biliary Stent System-Fully Covered
Evaluation for the Effectiveness of Evolution® Biliary Stent System-Fully Covered
Status: Enrolling
Updated: 2/2/2017
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Evolution® Biliary Stent System-Fully Covered
Evaluation for the Effectiveness of Evolution® Biliary Stent System-Fully Covered
Status: Enrolling
Updated:  2/2/2017
University of Virginia Health System
mi
from
Charlottesville, VA
Evolution® Biliary Stent System-Fully Covered
Evaluation for the Effectiveness of Evolution® Biliary Stent System-Fully Covered
Status: Enrolling
Updated: 2/2/2017
University of Virginia Health System
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Evolution® Biliary Stent System-Fully Covered
Evaluation for the Effectiveness of Evolution® Biliary Stent System-Fully Covered
Status: Enrolling
Updated:  2/2/2017
St. Michael's Hospital
mi
from
Toronto,
Evolution® Biliary Stent System-Fully Covered
Evaluation for the Effectiveness of Evolution® Biliary Stent System-Fully Covered
Status: Enrolling
Updated: 2/2/2017
St. Michael's Hospital
mi
from
Toronto,
Click here to add this to my saved trials
Gene Polymorphisms and Symptoms in Lung Cancer Patients
Gene Polymorphisms and Symptoms in Lung Cancer Patients
Status: Enrolling
Updated:  2/2/2017
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Gene Polymorphisms and Symptoms in Lung Cancer Patients
Gene Polymorphisms and Symptoms in Lung Cancer Patients
Status: Enrolling
Updated: 2/2/2017
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
A Study of Capecitabine In Combination With Docetaxel vs Capecitabine Followed by Docetaxel As First-Line Treatment For Metastatic Breast Cancer
Status: Enrolling
Updated:  2/2/2017
Clinical Research Facility
mi
from
Little Rock, AR
A Study of Capecitabine In Combination With Docetaxel vs Capecitabine Followed by Docetaxel As First-Line Treatment For Metastatic Breast Cancer
Status: Enrolling
Updated: 2/2/2017
Clinical Research Facility
mi
from
Little Rock, AR
Click here to add this to my saved trials
A Study of Capecitabine In Combination With Docetaxel vs Capecitabine Followed by Docetaxel As First-Line Treatment For Metastatic Breast Cancer
Status: Enrolling
Updated:  2/2/2017
mi
from
Deer Park, CA
A Study of Capecitabine In Combination With Docetaxel vs Capecitabine Followed by Docetaxel As First-Line Treatment For Metastatic Breast Cancer
Status: Enrolling
Updated: 2/2/2017
mi
from
Deer Park, CA
Click here to add this to my saved trials
A Study of Capecitabine In Combination With Docetaxel vs Capecitabine Followed by Docetaxel As First-Line Treatment For Metastatic Breast Cancer
Status: Enrolling
Updated:  2/2/2017
Clinical Research Facility
mi
from
Greenbrae, CA
A Study of Capecitabine In Combination With Docetaxel vs Capecitabine Followed by Docetaxel As First-Line Treatment For Metastatic Breast Cancer
Status: Enrolling
Updated: 2/2/2017
Clinical Research Facility
mi
from
Greenbrae, CA
Click here to add this to my saved trials
A Study of Capecitabine In Combination With Docetaxel vs Capecitabine Followed by Docetaxel As First-Line Treatment For Metastatic Breast Cancer
Status: Enrolling
Updated:  2/2/2017
Clinical Research Facility
mi
from
La Jolla, CA
A Study of Capecitabine In Combination With Docetaxel vs Capecitabine Followed by Docetaxel As First-Line Treatment For Metastatic Breast Cancer
Status: Enrolling
Updated: 2/2/2017
Clinical Research Facility
mi
from
La Jolla, CA
Click here to add this to my saved trials
A Study of Capecitabine In Combination With Docetaxel vs Capecitabine Followed by Docetaxel As First-Line Treatment For Metastatic Breast Cancer
Status: Enrolling
Updated:  2/2/2017
Clinical Research Facility
mi
from
Los Angeles, CA
A Study of Capecitabine In Combination With Docetaxel vs Capecitabine Followed by Docetaxel As First-Line Treatment For Metastatic Breast Cancer
Status: Enrolling
Updated: 2/2/2017
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Study of Capecitabine In Combination With Docetaxel vs Capecitabine Followed by Docetaxel As First-Line Treatment For Metastatic Breast Cancer
Status: Enrolling
Updated:  2/2/2017
Clinical Research Facility
mi
from
Orange, CA
A Study of Capecitabine In Combination With Docetaxel vs Capecitabine Followed by Docetaxel As First-Line Treatment For Metastatic Breast Cancer
Status: Enrolling
Updated: 2/2/2017
Clinical Research Facility
mi
from
Orange, CA
Click here to add this to my saved trials
A Study of Capecitabine In Combination With Docetaxel vs Capecitabine Followed by Docetaxel As First-Line Treatment For Metastatic Breast Cancer
Status: Enrolling
Updated:  2/2/2017
Clinical Research Facility
mi
from
Aurora, CO
A Study of Capecitabine In Combination With Docetaxel vs Capecitabine Followed by Docetaxel As First-Line Treatment For Metastatic Breast Cancer
Status: Enrolling
Updated: 2/2/2017
Clinical Research Facility
mi
from
Aurora, CO
Click here to add this to my saved trials
A Study of Capecitabine In Combination With Docetaxel vs Capecitabine Followed by Docetaxel As First-Line Treatment For Metastatic Breast Cancer
Status: Enrolling
Updated:  2/2/2017
Clinical Research Facility
mi
from
Boca Raton, FL
A Study of Capecitabine In Combination With Docetaxel vs Capecitabine Followed by Docetaxel As First-Line Treatment For Metastatic Breast Cancer
Status: Enrolling
Updated: 2/2/2017
Clinical Research Facility
mi
from
Boca Raton, FL
Click here to add this to my saved trials
A Study of Capecitabine In Combination With Docetaxel vs Capecitabine Followed by Docetaxel As First-Line Treatment For Metastatic Breast Cancer
Status: Enrolling
Updated:  2/2/2017
Clinical Research Facility
mi
from
Boynton Beach, FL
A Study of Capecitabine In Combination With Docetaxel vs Capecitabine Followed by Docetaxel As First-Line Treatment For Metastatic Breast Cancer
Status: Enrolling
Updated: 2/2/2017
Clinical Research Facility
mi
from
Boynton Beach, FL
Click here to add this to my saved trials
A Study of Capecitabine In Combination With Docetaxel vs Capecitabine Followed by Docetaxel As First-Line Treatment For Metastatic Breast Cancer
Status: Enrolling
Updated:  2/2/2017
Clinical Research Facility
mi
from
Brooksville, FL
A Study of Capecitabine In Combination With Docetaxel vs Capecitabine Followed by Docetaxel As First-Line Treatment For Metastatic Breast Cancer
Status: Enrolling
Updated: 2/2/2017
Clinical Research Facility
mi
from
Brooksville, FL
Click here to add this to my saved trials
A Study of Capecitabine In Combination With Docetaxel vs Capecitabine Followed by Docetaxel As First-Line Treatment For Metastatic Breast Cancer
Status: Enrolling
Updated:  2/2/2017
Clinical Research Facility
mi
from
Hollywood, FL
A Study of Capecitabine In Combination With Docetaxel vs Capecitabine Followed by Docetaxel As First-Line Treatment For Metastatic Breast Cancer
Status: Enrolling
Updated: 2/2/2017
Clinical Research Facility
mi
from
Hollywood, FL
Click here to add this to my saved trials
A Study of Capecitabine In Combination With Docetaxel vs Capecitabine Followed by Docetaxel As First-Line Treatment For Metastatic Breast Cancer
Status: Enrolling
Updated:  2/2/2017
Clinical Research Facility
mi
from
New Port Richey, FL
A Study of Capecitabine In Combination With Docetaxel vs Capecitabine Followed by Docetaxel As First-Line Treatment For Metastatic Breast Cancer
Status: Enrolling
Updated: 2/2/2017
Clinical Research Facility
mi
from
New Port Richey, FL
Click here to add this to my saved trials
A Study of Capecitabine In Combination With Docetaxel vs Capecitabine Followed by Docetaxel As First-Line Treatment For Metastatic Breast Cancer
Status: Enrolling
Updated:  2/2/2017
Clinical Research Facility
mi
from
Augusta, GA
A Study of Capecitabine In Combination With Docetaxel vs Capecitabine Followed by Docetaxel As First-Line Treatment For Metastatic Breast Cancer
Status: Enrolling
Updated: 2/2/2017
Clinical Research Facility
mi
from
Augusta, GA
Click here to add this to my saved trials
A Study of Capecitabine In Combination With Docetaxel vs Capecitabine Followed by Docetaxel As First-Line Treatment For Metastatic Breast Cancer
Status: Enrolling
Updated:  2/2/2017
Clinical Research Facility
mi
from
Savannah, GA
A Study of Capecitabine In Combination With Docetaxel vs Capecitabine Followed by Docetaxel As First-Line Treatment For Metastatic Breast Cancer
Status: Enrolling
Updated: 2/2/2017
Clinical Research Facility
mi
from
Savannah, GA
Click here to add this to my saved trials
A Study of Capecitabine In Combination With Docetaxel vs Capecitabine Followed by Docetaxel As First-Line Treatment For Metastatic Breast Cancer
Status: Enrolling
Updated:  2/2/2017
Clinical Research Facility
mi
from
Chicago, IL
A Study of Capecitabine In Combination With Docetaxel vs Capecitabine Followed by Docetaxel As First-Line Treatment For Metastatic Breast Cancer
Status: Enrolling
Updated: 2/2/2017
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
A Study of Capecitabine In Combination With Docetaxel vs Capecitabine Followed by Docetaxel As First-Line Treatment For Metastatic Breast Cancer
Status: Enrolling
Updated:  2/2/2017
Clinical Research Facility
mi
from
Skokie, IL
A Study of Capecitabine In Combination With Docetaxel vs Capecitabine Followed by Docetaxel As First-Line Treatment For Metastatic Breast Cancer
Status: Enrolling
Updated: 2/2/2017
Clinical Research Facility
mi
from
Skokie, IL
Click here to add this to my saved trials